A follow-up magnetic resonance imaging study of schizophrenia: Relationship of neuroanatomical changes to clinical and neurobehavioral measures

Archives of General Psychiatry

Volumn 55, Issue 2, 1998, Pages 145-152

  Gur, Raquel E ^a   Cowell, Patricia ^a   Turetsky, Bruce I ^a   Gallacher, Fiona ^a   Cannon, Tyrone ^a   Bilker, Warren ^a   Gur, Ruben C ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NEUROLEPTIC AGENT;

ARTICLE; BRAIN SIZE; CONTROLLED STUDY; DOSE RESPONSE; FEMALE; FOLLOW UP; FRONTAL LOBE; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL FUNCTION; NUCLEAR MAGNETIC RESONANCE IMAGING; SCHIZOPHRENIA; SYMPTOMATOLOGY;

ADULT; BRAIN; CROSS-SECTIONAL STUDIES; FEMALE; FOLLOW-UP STUDIES; FRONTAL LOBE; HUMANS; LONGITUDINAL STUDIES; MAGNETIC RESONANCE IMAGING; MALE; NEUROPSYCHOLOGICAL TESTS; PSYCHIATRIC STATUS RATING SCALES; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; SEVERITY OF ILLNESS INDEX; TEMPORAL LOBE;

EID: 0031934466     PISSN: 0003990X     EISSN: None     Source Type: Journal    
DOI: 10.1001/archpsyc.55.2.145     Document Type: Article

References (60)

1. Coffman JA. Computed tomography in psychiatry. In: Andreasen NC, ed. Brain Imaging: Applications in Psychiatry. Washington, DC: American Psychiatric Press; 1989:1-65.
2. Andreasen NC, Ehrnardt JC, Swayze V II, Alliger RJ, Yuh WTC, Cohen G, Ziebell S. Magnetic resonance imaging of the brain in schizophrenia: the pathophysiologic significance of structural abnormalities. Arch Gen Psychiatry. 1990;47:35-44.
3. Breier A, Buchanan RW, Elkashef A, Munson RC, Kirkpatrick B, Gellad F. Brain morphology and schizophrenia: a magnetic resonance imaging study of limbic, prefrontal cortex, and caudate structures. Arch Gen Psychiatry. 1992;49:921-926.
4. Suddath RL, Casanova MF, Goldberg TE, Daniel DG, Kelsoe JR, Weinberger DR. Temporal lobe pathology in schizophrenia. Am J Psychiatry. 1989;146:464-472.
5. Barta PE, Pearlson GD, Powers RE, Richards SS, Tune LE. Auditory hallucinations and smaller superior temporal gyral volume in schizophrenia. Am J Psychiatry. 1990;147:1457-1462.
6. Shenton ME, Kikinis R, Jolesz FA, Pollak SD, LeMay M, Wible CG, Hokama H, Martin J, Metcalf D, Coleman M, McCarley RW. Abnormalities of the left temporal lobe and thought disorder in schizophrenia: a quantitative magnetic resonance imaging study. N Engl J Med. 1992;327:604-612.
7. Nasrallah HA, Oison SC, McCalley-Whitters M, Chapman S, Jacoby CG. Cerebral ventricular enlargement in schizophrenia. Arch Gen Psychiatry. 1986;43:157-159.
8. Pillowsky B, Juliano DM, Bigelow LB, Weinberger DR. Stability of CT scan findings in schizophrenia: results of an 8 year follow-up study. J Neurol Neurosurg Psychiatr. 1988;51:209-213.
9. Vita A, Sacchetti E, Valvassori G, Cazzullo CL. Brain morphology in schizophrenia: a 2 to 5 year CT scan follow-up study. Acta Psychiatr Scand. 1988;78:618-621.
10. Hoffman WF, Ballard L, Turner EH, Casey DE. Three-year follow-up of older schizophrenics: extrapyramidal syndromes, psychiatric symptoms, and ventricular brain ratio. Biol Psychiatry. 1991;30:913-926.
11. Sponheim SR, Iacono WG, Beiser M. Stability of ventricular size after the onset of psychosis in schizophrenia. Psychiatry Res Neuroimaging. 1991;40:21-29.
12. Kemali D, Maj M, Galderisi S, Milici N, Dalvati A. Ventricle-to-brain ratio in schizophrenia: a controlled follow-up study. Biol Psychiatry. 1989;26:753-756.
13. Woods BT, Yurgelum-Todd D, Benes FM, Frankenburg FR, Pope HG Jr, McSparren J. Progressive ventricular enlargement in schizophrenia: comparison to bipolar affective disorder and correlation with clinical course. Biol Psychiatry. 1990;27:341-352.
14. Degreef G, Ashtari M, Bogerts B, Bilder RM, Jody DN, Alvir JM, Lieberman JA. Volumes of ventricular system subdivisions measured from magnetic resonance images in first-episode schizophrenic patients. Arch Gen Psychiatry. 1992;49:531-537.
15. DeLisi LE, Hoff AL, Schwartz JE, Shields GW, Halthore SN, Gupta SM, Henn FA, Anand AK. Brain morphology in first-episode schizophrenic-like psychotic patients: a quantitative magnetic resonance imaging study. Biol Psychiatry. 1991;29:159-175.
16. DeLisi LE, Stritzke P, Riordan H, Holan V, Boccio A, Kushner M, McClelland J, Van Eyl O, Anand A. The timing of brain morphological changes in schizophrenia and their relationship to clinical outcome. Biol Psychiatry. 1992;31:241-254.
17. DeLisi LE, Tew W, Xie S, Hoff AL, Sakuma M, Kushner M, Lee G, Shedlack K, Smith AM, Grimson R. A prospective follow-up study of brain morphology and cognition in first-episode schizophrenic patients: preliminary findings, Biol Psychiatry. 1995;38:349-360.
18. Gur RC, Mozley PD, Resnick SM, Gottlieb GE, Kohn M, Zimmerman R, Herman G, Atlas S, Grossman R, Berretta D, Erwin R, Gur RE. Gender differences in age effect on brain atrophy measured by magnetic resonance imaging. Proc Natl Acad Sci USA. 1991;88:2845-2849.
19. Cowell PE, Turetsky BT, Gur RC, Grossman RI, Shtasel DL, Gur RE. Sex differences in aging of the human frontal and temporal lobe. J Neurosci. 1994;14:4748-4755.
20. Coffey C, Wilkinson W, Parashos I, Soady S, Sullivan R, Patterson L, Figiet G, Webb M, Spritzer C, Djang W. Quantitative cerebral anatomy of the aging human brain: a cross-sectional study using magnetic resonance imaging. Neurology. 1992;42:527-536.
21. Condon B, Grant R, Hadley D, Lawrence A. Brain and intracranial cavity volumes: in vivo determination by MRI. Acta Neuroi Scand. 1988;78:387-393.
22. Kohn MI, Tanna NK, Herman GT, Resnick SM, Mozley PD, Gur RE, Alavi A, Zimmerman RA, Gur RC. Analysis of brain and CSF volumes from magnetic resonance imaging: methodology, reliability and validation. Radiology. 1991;178:115-122.
23. Gur RE, Mozley PD, Resnick SM, Shtasel D, Kohn M, Zimmerman R, Herman G, Atlas S, Grossman R, Erwin R, Gur RC. Magnetic resonance imaging in schizophrenia, I: volumetric analysis of brain and cerebrospinal fluid. Arch Gen Psychiatry. 1991;48:407-412.
24. Mozley PD, Gur RE, Shtasel DL, Resnick SM, Richards J, Kohn M, Grossman R, Herman G, Gur RC. Magnetic resonance imaging in schizophrenia, II: relationship to clinical measures. Schizophr Res. 1994;12:195-203.
25. Gur RE, Mozley PD, Shtasel DL, Cannon TD, Gallacher F, Turetsky B, Grossman R, Gur RC. Clinical subtypes of schizophrenia differ in brain and cerebrospinal fluid volume. Am J Psychiatry. 1994;151:343-350.
26. Turetsky BT, Cowell PE, Gur RC, Grossman RI, Shtasel DL, Gur RE. Frontal and temporal lobe brain volumes in schizophrenia: relationship to symptomatology and clinical subtype. Arch Gen Psychiatry. 1995;52:1061-1070.
27. Cowell PE, Kostianovsky DJ, Gur RC, Turetsky BI, Gur RE. Sex differences in neu- roanatomical and clinical correlations in schizophrenia. Am J Psychiatry. 1996;153:799-805.
28. Spitzer RL, Williams JBW, Gibbon M. Structured Clinical Interview for DSM-III-R, Patient Version (SCID-P). New York, NY: New York State Psychiatric Institute: 1986.
29. Gur RE, Mozley D, Resnick SM, Levick S, Erwin R, Saykin AJ, Gur RC. Relations among clinical scales in schizophrenia: overlap and subtypes. Am J Psychiatry. 1991;148:472-478.
30. Spitzer RL, Williams JBW, Gibbon M, Structured Clinical Interview for DSM-III-R: Non-Patient Version (SCID-NP). New York, NY: New York State Psychiatric Institute; 1989.
31. Shtasel DL, Gur RE, Mozley PD, Richards J, Taleff MM, Heimberg C, Gallacher F, Gur RC. Volunteers for biomedical research; recruitment and screening of normal controls. Arch Gen Psychiatry. 1991;48:1022-1025.
32. Kaplan HI, Sadock BI. Synopsis of Psychiatry. 6th ed. Baltimore, Md: Williams & Wilkins; 1992:639.
33. Andreasen NC. The Scale for the Assessment of Negative Symptoms (SANS). Iowa City, Iowa: The University of Iowa; 1984.
34. Andreasen NC. The Scale for the Assessment of Positive Symptoms (SAPS). Iowa City, Iowa: The University of Iowa; 1984.
35. Saykin AJ, Gur RC, Gur RE, Mozley D, Mozley LH, Resnick SM, Kester DB, Stafiniak P. Neuropsychological function in schizophrenia: selective impairment in memory and learning. Arch Gen Psychiatry. 1991;48:618-624.
36. Saykin AJ, Shtasel DL, Gur RE, Kester DB, Mozley LH, Stafiniak P, Gur RC. Neuropsychological deficits in neuroleptic-naive, first-episode schizophrenic patients. Arch Gen Psychiatry. 1994;51:124-131.
37. Saykin AJ, Gur RC, Gur RE, Shtasel DL, Flannery KA, Mozley LH, Malamut BL, Watson B, Mozley PD. Normative neuropsychological test performance: effects of age, education, gender and ethnicity. Appl Neuropsychol. 1995;2:79-88.
38. Kareken DA, Gur RC, Mozley PD, Mozley LH, Saykin AJ, Shtasel DL, Gur RE. Cognitive functioning and neuroanatomic volume measures in schizophrenia. Neuropsychology. 1995;9:211-219.
39. Rothman KJ. No adjustments are needed for multiple comparisons. Epidemiology. 1990;1:43-46.
40. Miettinen OS. Theoretical Epidemiology. New York, NY: John Wiley & Sons; 1985:114-116.
41. Walker AM. Reporting the results of epidemiologic studies. Am J Public Health. 1986;75:577-558.
42. Szymanski S, Cannon TD, Gallacher F, Erwin R, Gur RE. The course of treatment response in first-episode and chronic schizophrenia. Am J Psychiatry. 1996;153:519-525.
43. Shtasel DL, Gur RE, Gallacher F, Heimberg C, Cannon TD, Gur RC. Phenomenology and functioning in first episode schizophrenia. Schizophr Bull. 1992;18:449-462.
44. Ram R, Bromet EG, Eaton WW, Pato C, Schwartz JE. The natural course of schizophrenia: a review of first admission studies. Schizophr Bull. 1992;18:182-207.
45. Eatpm WW, Thara R, Federman B, Melton B, Liang K. Structure and course of positive and negative symptoms in schizophrenia. Arch Gen Psychiatry. 1995;52:127-134.
46. Lieberman JA, Alvir JA, Woerner M, Degreef G, Bilder R, Ashtari M, Bogarts B, Mayerhoff D, Geisler S, Loebel A, Levy DL, Hinrichsen G, Szymanski S, Chakos M, Koreen A, Borenstein M, Kane J. Prospective study of psychobiology in first-episode schizophrenia at Hillside Hospital. Schizophr Bull. 1992;18:351-371.
47. Nopoulos P, Flashman L, Flaum M, Arndt S, Andreasen N. Stability of cognitive functioning early in the course of schizophrenia. Schizophr Res. 1994;14:29-37.
48. Goldberg TE, Hyde TM, Kleinman JE, Weinberger DR. Course of schizophrenia: neuropsychological evidence for a static encephalopathy. Schizophr Bull. 1993;19:797-804.
49. Bilder RM, Lipschutz-Broch L, Reiter G, Geisler SH, Mayerhoff DI, Lieberman JA. Intellectual deficits in first-episode schizophrenia: evidence for progressive deterioration. Schizophr Bull. 1992;18:437-448.
50. Jernigan TL, Trauner DA, Hesselink JR, Tallal PA. Maturation of human cerebrum observed in vivo during adolescence. Brain. 1991;114:2037-2049.
51. Shapiro RM. Regional neuropathology in schizophrenia: where are we? where are we going? Schizophr Res. 1993;10:187-239.
52. Arnold SE, Franz BR, Trojanowski JQ, Moberg PJ, Gur RE. Glial fibrillary acidic protein-immunoreactive astrocytosis in elderly patients with schizophrenia and dementia. Acta Neuropathol. 1996;91:269-277.
53. Arnold SE, Franz BR, Gur RC, Gur RE, Shapiro RM, Moberg PJ, Trojanowski JQ. Smaller neuron size in schizophrenia in hippocampal subfields that mediate cortical- . hippocampal interactions. Am J Psychiatry. 1995;152:738-748.
54. Jeste DV, Lohr JB, Manley M. Study of neuropathological changes in the striaturn following 4, 8 and 12 months of treatment with fluphenazine in rats. Psychopharmacology. 1992;106:154-160.
55. Benes FM, Paskevich PA, Domesick V. Haloperidol-induced plasticity of axon terminals in rat substantia nigra. Science. 1983;221:969-971.
56. Baldessarini RJ, Hegarty JD, Bird ED, Benes FM. Meta-analysis of postmortem studies of Alzheimer's disease-like neuropathology in schizophrenia. Am J Psychiatry. 1997;154:861-863.
57. Carpenter WT, Heinrichs DW, Wagman AMI. Deficit and nondeficit forms of schizophrenia: the concept. Am J Psychiatry. 1988;145:578-583.
58. Weinberger DR. Implications of normal brain development for the pathogenesis of schizophrenia. Arch Gen Psychiatry. 1987;44:660-669.
59. Wyatt RJ. Neurodevelopmental abnormalities and schizophrenia: a family affair. Arch Gen Psychiatry. 1996;53:11-15.
60. Olney JW, Farber NB. Glutamate receptor dysfunction and schizophrenia. Arch Gen Psychiatry. 1995;52:998-1007.